NASH (Non-Alcoholic Steatohepatitis) Biomarkers Market Report 2018-2025: AstraZeneca, Novartis AG, Allergan Plc, Pfizer Inc, GENFIT SA
The Study Paper on Top key vendors in NASH (Non-alcoholic Steatohepatitis) Biomarkers Market included is GENFIT SA, Gilead Sciences, Inc. (GILD), AstraZeneca, Novartis AG, Bristol-Myers Squibb Company, Allergan Plc, Novo Nordisk A/S, Boehringer Ingelheim, Pfizer Inc.
View full press release